Andorra Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Andorra Health Watch.

Press releases published on September 1, 2026

5 hours ago

Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter

Indeterminate GlobeNewswire

5 hours ago

CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth

Indeterminate GlobeNewswire

5 hours ago

Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

Indeterminate GlobeNewswire

5 hours ago

Applied Biologics Activates First Clinical Site in Phase 3 BIOxHEAL™ Trial

Indeterminate GlobeNewswire

6 hours ago

Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

Indeterminate GlobeNewswire

6 hours ago

NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications

Indeterminate GlobeNewswire

6 hours ago

Clearmind Reaches Key Milestone: CMND-100 Phase IIa now Underway for Alcohol Use Disorder Trial, One-Third of Part C Enrolled

Indeterminate GlobeNewswire

6 hours ago

FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

6 hours ago

BridgeBio to Participate in September Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

Vera Therapeutics to Participate at Upcoming Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

Ardelyx to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

F2G Announces Posters Accepted for Presentation at Upcoming Medical Meetings

Indeterminate GlobeNewswire

6 hours ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

6 hours ago

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Indeterminate GlobeNewswire

6 hours ago

Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE)

Indeterminate GlobeNewswire

6 hours ago

Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer

Indeterminate GlobeNewswire

6 hours ago

Kura Oncology to Participate in Three Investor Conferences in September

Indeterminate GlobeNewswire

6 hours ago

Ocugen Announces First Patient Dosed in Phase 3 Registrational Trial of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Indeterminate GlobeNewswire

6 hours ago

Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY

Indeterminate GlobeNewswire